Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by geos571on Jan 07, 2015 6:23pm
245 Views
Post# 23296131

RE:Welcome back C99 and Schaff -----------

RE:Welcome back C99 and Schaff -----------

Will they choose the cash payout difference ....or keep what they have only now credited at todays value and not the $1.59 ?......

 

Stock Appreciation Rights (SAR)
Stock Appreciation Rights provide the holder with the right to the appreciation on the underlying stock at a later date, based on a price that is preset at the time of grant. Typically the base price is set to 100% of the fair market value on the date of grant. SAR holders can choose when they would like to exercise their rights, generally any time after the SARs are vested. A company must determine a “fair value” using an option-pricing model to determine the compensation expense associated with each stock option share. The compensation expense is amortized over the vesting schedule of the rights. SARs can be settled in either cash or stock. If settled in cash they are treated as a  liability for accounting purposes and are subject to mark to market accounting. If settled in stock they are treated, for accounting purposes, in the same manner as stock options."
  
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse